Trials / Not Yet Recruiting
Not Yet RecruitingNCT07301437
RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.
A Real-world Study of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the differences in weight loss between liraglutide monotherapy and combined with orlistat in overweight/obese patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | liraglutide monotherapy | liraglutide monotherapy |
| DRUG | liraglutide combined with orlistat | combination therapy |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2027-08-31
- Completion
- 2027-08-31
- First posted
- 2025-12-24
- Last updated
- 2026-03-23
Source: ClinicalTrials.gov record NCT07301437. Inclusion in this directory is not an endorsement.